Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier Giorgio Natali

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Neoplasia (New York, N.Y.)|October 5, 2011
Human leukocyte antigen E contributes to protect tumor cells from lysis by natural killer cellsElisa Lo Monaco, Elisa Tremante, Cristina Cerboni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2011
Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cellsLaura Rosanò, Roberta Cianfrocca, Francesca Spinella, et al.
Anticancer Research|March 14, 2007
Prognostic factors in Hungarian breast cancer patientsEdit Nádasi, Béla Anga, János Sándor, et al.
Cancer Research|December 17, 2005
Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cellsLaura Rosanò, Francesca Spinella, Valeriana Di Castro, et al.
International Journal of Cancer|June 12, 2003
c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571Roberta Vitali, Vincenzo Cesi, Maria Rita Nicotra, et al.
Clinical Science (London, England : 1979)|August 24, 2002
ABT-627, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma growth in vitroDebora Salani, Laura Rosanò, Valeriana Di Castro, et al.
Breast Cancer Research : BCR|May 14, 2010
Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cellsLuisa Paris, Serena Cecchetti, Francesca Spadaro, et al.
Cancer Research|November 8, 2014
Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapyLaura Rosanò, Roberta Cianfrocca, Piera Tocci, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2009
Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasisLaura Rosanò, Roberta Cianfrocca, Stefano Masi, et al.
Anticancer Research|August 15, 2002
Differential expression of UN1, early thymocyte-associated sialoglycoprotein, in breast normal tissue, benign disease and carcinomasPierfrancesco Tassone, Patrizia Bonelli, Franca Tuccillo, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Neoplasia (New York, N.Y.)|October 5, 2011
Human leukocyte antigen E contributes to protect tumor cells from lysis by natural killer cellsElisa Lo Monaco, Elisa Tremante, Cristina Cerboni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2011
Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cellsLaura Rosanò, Roberta Cianfrocca, Francesca Spinella, et al.
Anticancer Research|March 14, 2007
Prognostic factors in Hungarian breast cancer patientsEdit Nádasi, Béla Anga, János Sándor, et al.
Cancer Research|December 17, 2005
Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cellsLaura Rosanò, Francesca Spinella, Valeriana Di Castro, et al.
International Journal of Cancer|June 12, 2003
c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571Roberta Vitali, Vincenzo Cesi, Maria Rita Nicotra, et al.
Clinical Science (London, England : 1979)|August 24, 2002
ABT-627, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma growth in vitroDebora Salani, Laura Rosanò, Valeriana Di Castro, et al.
Breast Cancer Research : BCR|May 14, 2010
Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cellsLuisa Paris, Serena Cecchetti, Francesca Spadaro, et al.
Cancer Research|November 8, 2014
Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapyLaura Rosanò, Roberta Cianfrocca, Piera Tocci, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2009
Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasisLaura Rosanò, Roberta Cianfrocca, Stefano Masi, et al.
Anticancer Research|August 15, 2002
Differential expression of UN1, early thymocyte-associated sialoglycoprotein, in breast normal tissue, benign disease and carcinomasPierfrancesco Tassone, Patrizia Bonelli, Franca Tuccillo, et al.
Pageof 10